The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacodynamic characterization of eryaspase (L-asparaginase encapsulated in red blood cells) in combination with chemotherapy in a phase 2/3 trial in patients with relapsed acute lymphoblastic leukemia (NCT01518517).
 
Iman El-Hariry
Employment - ERYTECH Pharma
Leadership - ERYTECH Pharma
Stock and Other Ownership Interests - ERYTECH Pharma
 
Karine Aguera
Employment - ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - ERYTECH Pharma
 
Frank Hoke
Employment - PAREXEL
Leadership - PAREXEL
Stock and Other Ownership Interests - PAREXEL
 
Kenneth Swart
Consulting or Advisory Role - ERYTECH Pharma
 
Adam Hamm
Employment - Cytel
Consulting or Advisory Role - Cytel
 
Richard Kay
Stock and Other Ownership Interests - PAREXEL; PAREXEL (I)
Consulting or Advisory Role - ERYTECH Pharma
 
Philip Lorenzi
Consulting or Advisory Role - ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - U.S. National Institutes of Health
Travel, Accommodations, Expenses - ERYTECH Pharma